Merck & Co., Inc. Acquires Part of Bankrupt Hawaii Biotech, Inc.

Star Advertiser -- Pharmaceutical giant Merck & Co. has agreed to buy Hawaii Biotech's dengue fever vaccine research unit, giving the local company needed capital as it works toward emerging from bankruptcy.